Acting on sex and gender in medical innovation is good for business.
Vijayasingham, Lavanya
; Bischof, Evelyne; Ateghang-Awankem, Bernadette; Rumaney, Maryam; Otmani Del Barrio, Mariam; Cheah, Phaik Yeong; Ter-Meulen, Ajoke Sobanjo; Tannenbaum, Cara; Morgan, Rosemary; Wolfe, Jeannette; and +1 more...Gender and Covid-19 Research Agenda Setting Initiative
(2023)
Acting on sex and gender in medical innovation is good for business.
BMJ (Clinical research ed.), 381.
e072242-.
ISSN 0959-8138
DOI: 10.1136/bmj-2022-072242
; Bischof, Evelyne; Ateghang-Awankem, Bernadette; Rumaney, Maryam; Otmani Del Barrio, Mariam; Cheah, Phaik Yeong; Ter-Meulen, Ajoke Sobanjo; Tannenbaum, Cara; Morgan, Rosemary; Wolfe, Jeannette; and +1 more...Gender and Covid-19 Research Agenda Setting Initiative
(2023)
Acting on sex and gender in medical innovation is good for business.
BMJ (Clinical research ed.), 381.
e072242-.
ISSN 0959-8138
DOI: 10.1136/bmj-2022-072242
Lavanya Vijayasingham and colleagues argue that as well as improving safety and efficacy, considering sex and gender related factors in medical research can have commercial benefits
-
picture_as_pdf - Vijayasingham-etal-2023-Acting-on-sex-and-gender-in-medical-innovation.pdf
-
subject - Published Version
-
- Available under Creative Commons: Attribution 4.0
Downloads